Patent details

Basic Information

Publication number:

91943

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP971227020

Legal Status:

Expired

Application number:

91943

First applicant's nationality:

Procedural language:

French

Marketing Authorization

1

Marketing Authorization Number:

43230 - TAFLOTAN

Marketing Authorization Type:

Marketing Authorization Date:

30/04/2008

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Denmark (DK)

2

Marketing Authorization Number:

0483/11080052 - SAFLUTAN - TAFLUPROST

Marketing Authorization Type:

Marketing Authorization Date:

18/08/2011

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

15/02/2012

First Marketing Authorization date:

30/04/2008

Grant date:

16/04/2012

Activation date:

22/12/2017

Publication date:

16/04/2012

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

22/12/2022

SPC Extension Expiration:

22/12/2022

Rejection date:

Withdrawal date:

Owner

From:

02/10/2018

 

 

Name:

AGC Inc.

Address:

5-1, Marunouchi 1-chome, Chiyoda-ku, Tokyo 100-8405, Japan (JP)

Name:

SANTEN PHARMACEUTICAL CO. LTD.

Address:

9-19, Shimoshinjo 3-chome, Higashiyodogawa-ku, Osaka-shi, Osaka 533, Japan (JP)

History of Owners

From:

15/02/2012

To:

02/10/2018

Name:

ASAHI GLASS COMPANY LTD.

Address:

12-1, Yurakucho 1-chome, Chiyoda-ku, Tokyo 100-8405, Japan (JP)

Name:

SANTEN PHARMACEUTICAL CO. LTD.

Address:

9-19, Shimoshinjo 3-chome, Higashiyodogawa-ku, Osaka-shi, Osaka 533, Japan (JP)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

15/02/2012

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Nakano Takashi, Asahi Glass Company Ltd.

Address:

Japan (JP)

2

Name:

Kageyama Masaaki, Santen Pharmaceutical Co., Ltd.

Address:

Japan (JP)

3

Name:

Sasakura Hideshi, Asahi Glass Company Ltd.

Address:

Japan (JP)

4

Name:

Morizawa Yoshitomi, Asahi Glass Company Ltd.

Address:

Japan (JP)

5

Name:

Nakajima Tadashi, Santen Pharmaceutical Co., Ltd.

Address:

Japan (JP)

6

Name:

Matsumura Yasushi, Asahi Glass Company Ltd.

Address:

Japan (JP)

7

Name:

Shirasawa Eiichi, Santen Pharmaceutical Co., Ltd.

Address:

Japan (JP)

8

Name:

Mori Nobuaki, Asahi Glass Company Ltd.

Address:

Japan (JP)

Publication

Bulletin

1

Bulletin Heading:

CO

Bulletin edition number:

2018/12

Publication date:

15/11/2018

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:

SPC3

Bulletin edition number:

2018/02

Publication date:

15/01/2018

Description:

Section E : Supplementary Protection certificates entered into force – IA publication

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20180000320A

Date Registered:

02/10/2018

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

MARKS & CLERK LLP

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

1

Name:

SANTEN PHARMACEUTICAL CO. LTD.

Address:

9-19, Shimoshinjo 3-chome, Higashiyodogawa-ku, Osaka-shi, Osaka 533, Japan (JP)

2

Name:

AGC Inc.

Address:

5-1, Marunouchi 1-chome, Chiyoda-ku, Tokyo 100-8405, Japan (JP)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

22/12/2021

Last Annual Fee Paid Number:

25

Last Annual Fee Paid Amount:

450 Euro

Payer:

DENNEMEYER & CO

Filing date	Document type	Number of pages
02/10/2018	Outgoing Correspondence	1
02/10/2018	Request For Change	7